Alpelisib Terminated Phase 1 / 2 Trials for PIK3CA Amplified Advanced Solid Tumors / PIK3CA Mutated Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs